Duoresp Spiromax

/ Abic

Formulation of 160 mcg/4.5 mcg As monotherapy: To prevent recurrence of asthma symptoms.
Recommended dose (adults): One inhalation or 2 inhalations, twice a day. Dosage may be decreased to once a day, or increased to 4 inhalations, twice a day.
As combined treatment with a “supplementary inhaler”: Recommended dose (adults): One inhalation in the morning and one inhalation in the evening. Or 2 inhalations in the morning. Or 2 inhalations in the evening. May be increased to 2 inhalations twice a day.
Formulation of 320 mcg/9 mcg as monotherapy: Recommended dose (adults): One inhalation, twice a day. The dosage may be increased by the doctor to 2 inhalations twice a day, or decreased to once daily.
As combined treatment with a “supplementary inhaler”: Use a “supplementary inhaler” to relieve asthma symptoms when they occur. Always carry the “supplementary inhaler” with you for relief in the event of sudden attacks of breathlessness and wheezing. Do not use 320 mcg/9 mcg formulation to treat asthma symptoms.

Regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β2 adrenoceptor agonist) is appropriate: In patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled shortacting β2 adrenoceptor agonists. Or in patients already adequately controlled on both inhaled corticosteroids and long-acting β2 adrenoceptor agonists. Indicated  in adults 18 years of age and older only.

Known hypersensitivity to any of the active ingredients or to the excipient (lactose).